Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 34 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10125112

    Modulators of the relaxin receptor 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  2. US 10118948

    Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  3. US 10117947

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  4. US 10117942

    Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  5. US 10119172

    Methods and reagents for detecting ebola virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  6. US 10111927

    Pseudomonas exotoxin A with less immunogenic B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  7. US 10113183

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  8. US 10114019

    Bacterial challenge model in cattle using a trans- and intra-dermal route to infect peripheral lymph nodes

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  9. US 10105409

    Therapeutic use of chardonnay seed products

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  10. US 10106620

    Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  11. US 10100346

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  12. US 10098945

    Genetically engineered swine influenza virus and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  13. US 10092637

    Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  14. US 10093710

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  15. US 10094836

    SLCO1B3 genotype

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  16. US 10087230

    Murine anti-NY-ESO-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  17. US 10087148

    Quinazolines as biogenic amine transport modulators

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  18. US 10087211

    Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  19. US 10086061

    Combination purified inactivated vaccine for flaviviruses

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  20. US 10081658

    Truncated HIV envelope proteins (ENV), methods and compositions related thereto

    The United States of America as represented by the Secretary of the Army · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  21. US 10081659

    Adeno-associated vectors for enhanced transduction and reduced immunogenicity

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  22. US 10081669

    Therapy for filovirus infection

    The United States of America as represented by the Secretary of the Army · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  23. US 10077446

    Glucan-encapsulated siRNA for treating type 2 diabetes mellitus

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  24. US 10077296

    Methods and compositions for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.